List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 98 studies with search of: "Bicalutamide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: Panobinostat + bicalutamide;   Drug: Panobinosts+ bicalutamide;   Drug: Panibinostat + bicalutamide
2 Recruiting CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide and CP-675,206 (Tremelimumab);   Drug: Bicalutamide, CP-675,206 (tremelimumab);   Drug: Bicalutamide, CP-675,206 (Tremelimumab);   Drug: Bicalutamide, CP-675,206 (Tremelimumab);   Drug: Bicalutamide, CP-675,206
3 Recruiting Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
Conditions: Prostate Cancer;   Erectile Dysfunction;   Urinary Toxicity
Interventions: Drug: LHRH agonist and Bicalutamide;   Drug: Bicalutamide, Dutasteride and Tamoxifen
4 Completed Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
Condition: Non-Metastatic Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Placebo
5 Completed (Bicalutamide) Casodex vs Placebo in Non-Metastatic Early Prostate Cancer
Condition: Non-Metastatic Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Placebo
6 Not yet recruiting Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.
Condition: Prostate Cancer
Interventions: Drug: Vandetanib;   Drug: Bicalutamide
7 No longer available Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: Bicalutamide (Casodex)
8 Completed Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Bicalutamide
9 Completed Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Bicalutamide
10 Active, not recruiting Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Condition: Puberty, Precocious
Interventions: Drug: Bicalutamide;   Drug: Anastrozole
11 Recruiting RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: RAD001;   Drug: Bicalutamide
12 Completed Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: eflornithine;   Procedure: conventional surgery;   Radiation: brachytherapy
13 Recruiting External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: Radiation Therapy;   Drug: Bicalutamide;   Drug: Leuprolide;   Drug: Goserelin;   Drug: Flutamide;   Behavioral: Questionnaire
14 Completed Casodex vs Placebo in Non-Metastatic Early Prostate Cancer
Condition: Non-Metastatic Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Placebo
15 Completed Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: bicalutamide (Casodex), goserelin (Zoladex)
16 Recruiting Efficacy and Safety of Zactima™ in Patients With Castration-Refractory Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ZD6474 (Vandetanib);   Drug: Bicalutamide;   Drug: Placebo
17 Recruiting Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Conditions: Cancer;   Prostate Neoplasms
Interventions: Drug: goserelin with dutasteride;   Drug: goserelin with bicalutamide and dutasteride;   Drug: goserelin with bicalutamide and dutasteride and ketoconazole
18 Recruiting Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Leuprolide;   Drug: Goserelin;   Drug: Sunitinib Malate;   Drug: Bicalutamide;   Radiation: Radiation Therapy
19 Active, not recruiting Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 Mg in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Tamoxifen
20 Recruiting Bicalutamide in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bicalutamide;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services